Greiner, J., Schneider, V., Schmitt, M., Götz, M., Döhner, K., Wiesneth, M., . . . Hofmann, S. (2013). Immune responses against the mutated region of cytoplasmatic NPM1 might contribute to the favorable clinical outcome of AML patients with NPM1 mutations (NPM1mut). Blood, 122(6), . https://doi.org/10.1182/blood-2013-04-496844
Chicago Style (17th ed.) CitationGreiner, Jochen, Vanessa Schneider, Michael Schmitt, Marlies Götz, Konstanze Döhner, Markus Wiesneth, Hartmut Döhner, and Susanne Hofmann. "Immune Responses Against the Mutated Region of Cytoplasmatic NPM1 Might Contribute to the Favorable Clinical Outcome of AML Patients with NPM1 Mutations (NPM1mut)." Blood 122, no. 6 (2013). https://doi.org/10.1182/blood-2013-04-496844.
MLA (9th ed.) CitationGreiner, Jochen, et al. "Immune Responses Against the Mutated Region of Cytoplasmatic NPM1 Might Contribute to the Favorable Clinical Outcome of AML Patients with NPM1 Mutations (NPM1mut)." Blood, vol. 122, no. 6, 2013, https://doi.org/10.1182/blood-2013-04-496844.